Click on the image to visit the Congress Website
Let me start this editorial by warmly inviting you to attend the forthcoming ERA-EDTA Congress in Vienna, from May 21st to 24th. This will again be an excellent opportunity for networking, exchanging experiences with colleagues from the various fields of nephrology and from many countries, and attending high quality scientific sessions. In addition Vienna is a world-class city for culture!
Next let me present the 5 papers of this 312th issue.
NDT-EDUCATIONAL LATEST NEWS
A new study sheds light on how sleep apnea might worsen outcomes for cancer patients, revealing that hypoxia - a consequence of the sleep disorder - may promote blood vessel growth in tumors.
Yogurt may have a beneficial effect on women's blood pressure, especially when part of a healthy diet.
This was the conclusion of a study recently presented at the American Heart Association's (AHA's) Epidemiology/Lifestyle 2016 Scientific Sessions in Phoenix, AZ.
For some patients with type 2 diabetes, treatment with intense blood-lowering medication may do more harm than good. This is according to a new study published in The BMJ.
An implantable artificial kidney could transform prospects for people whose kidneys have failed and who have to rely on dialysis or the rare chance of a transplant to stay alive. Now, researchers working on the first-of-its-kind device that aims to meet this need says they are hopeful of running pilot trials in humans within the year.
As medical research continues to generate new technologies and drugs for a wide variety of uses, many questions arise regarding how such resources should be used and who should have access to them.